Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

Immune Disease Start-Up Raises $28M in Early Funds

A new company founded to develop treatments for diseases caused by problems with the immune system is raising $28.4 million in its first round of financing. . . . → Read More: Immune Disease Start-Up Raises $28M in Early Funds

Organ Chips to be Studied on Space Station

A range of biological functions will be assessed with model organs on plastic chips in a series of experiments on the International Space Station. . . . → Read More: Organ Chips to be Studied on Space Station

$300M Fund to Back European Life Science Companies

A new investment fund plans to invest $300 million in European life science and biotechnology companies in the later stages of their product development. . . . → Read More: $300M Fund to Back European Life Science Companies

Institutions to Apply AI Models to Type 1 Diabetes

A children’s hospital and diabetes research center are evaluating techniques using artificial intelligence to better identify and manage the care of people with type 1 diabetes. . . . → Read More: Institutions to Apply AI Models to Type 1 Diabetes

What Does The Future Hold For Investment?

The investment opportunities available to us in the modern day? They are large, wide and varied. . . . → Read More: What Does The Future Hold For Investment?

Report: Growing Tech Industry Investment in Health

The information technology industry is a growing presence in health care, both financially and qualitatively, according to a new report. . . . → Read More: Report: Growing Tech Industry Investment in Health

$10M Cancer Immunotherapy Research Fund Launched

A foundation is sponsoring research grants totaling $10 million for computational solutions to key questions facing cancer immunotherapy. . . . → Read More: $10M Cancer Immunotherapy Research Fund Launched

Fund Created for Point-of-Care Diagnostics, Treatment

A venture capital company is beginning a $60 million investment fund that plans to finance start-up enterprises providing point-of-care diagnostics and medical treatments. . . . → Read More: Fund Created for Point-of-Care Diagnostics, Treatment

Liquid Biopsy Company Gains $360M for Cancer Sequencing

A company using blood tests to diagnose cancer is receiving a $360 million investment for its campaign to sequence DNA from 1 million people at high risk of cancer. . . . → Read More: Liquid Biopsy Company Gains $360M for Cancer Sequencing

$2 Billion Biotech Licensing Deal Cancelled

A licensing deal with a potential value of more than $2 billion between two biotechnology companies for a new breast cancer drug was cancelled on Friday. . . . → Read More: $2 Billion Biotech Licensing Deal Cancelled